Loading...
Targeting BTK through microRNA in chronic lymphocytic leukemia
Bruton’s tyrosine kinase (BTK) is a critical mediator of survival in B-cell neoplasms. Although BTK inhibitors have transformed therapy in chronic lymphocytic leukemia (CLL), patients with high-risk genetics are at risk for relapse and have a poor prognosis. Identification of novel therapeutic strat...
Na minha lista:
| Udgivet i: | Blood |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Hematology
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5201097/ https://ncbi.nlm.nih.gov/pubmed/27756747 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-07-727750 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|